Acute rhabdomyolysis as a complication of cytarabine chemotherapy for acute myeloid leukemia: Case report and review of literature
Authors:
Open Access
- 26 July 2002
- journal article
- review article
- Published by Wiley in American Journal of Hematology
- Vol. 70 (4) , 320-323
Abstract
Rhabdomyolysis is an unusual complication of chemotherapy that can lead to substantial morbidity through such complications as renal failure, infections, and disseminated intravascular coagulation. The syndrome has been described after treatment with cyclophosphamide, 5‐azacytidine, interleukin‐2, and interferon and after bone marrow transplantation. We report a patient with acute myeloid leukemia who developed fulminant rhabdomyolysis after treatment with a cytarabine‐containing regimen. The syndrome was complicated by acute renal failure requiring hemodyalisis, respiratory insufficiency, and pancreatitis. We suggest that the muscle damage might be related to the known ability of cytarabine to trigger the release of cytochrome c from the mitochondria, which could lead to uncoupling of the oxidative phosphorylation with subsequent depletion of ATP reserves at the skeletal muscle and rhabdomyolysis. Am. J. Hematol. 70:320–323, 2002.Keywords
This publication has 10 references indexed in Scilit:
- A double-blind, placebo-controlled trial of pegylated recombinant human megakaryocyte growth and development factor as an adjunct to induction and consolidation therapy for patients with acute myeloid leukemiaBlood, 2000
- A Randomized, Double-Blind, Placebo-Controlled Study With Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (PEG-rHuMGDF) as an Adjunct to Chemotherapy for Adults With De Novo Acute Myeloid LeukemiaBlood, 1999
- Activation of the CPP32 protease in apoptosis induced by 1-beta-D- arabinofuranosylcytosine and other DNA-damaging agentsBlood, 1996
- Rhabdomyolysis: An unusual complication of cytotoxic chemotherapyMedical Oncology, 1995
- Acute rhabdomyolysis after concurrent administration of interleukin-2, interferon-alfa, and chemotherapy for metastatic melanomaCancer, 1995
- Intensive Postremission Chemotherapy in Adults with Acute Myeloid LeukemiaNew England Journal of Medicine, 1994
- Chemotherapy-Related Acute RhabdomyolysisJNCI: Journal of the National Cancer Institute, 1992
- 1-β-D-arabinofuranosylcytosine (Ara-C) enhances mitochondrial activities in human leukaemic cellsBritish Journal of Cancer, 1991
- Drug- and toxin-induced rhabdomyolysisAnnals of Emergency Medicine, 1989
- Bacillus cereus septicemia associated with rhabdomyolysis and myoglobinuric renal filure.Japanese Journal of Medicine, 1989